Keith M Olson
Affiliations: | University of Michigan, Ann Arbor, Ann Arbor, MI |
Area:
Biochemistry, Opioids, Pharmacology, Peptide Chemistry, ChemistryGoogle:
"Keith Olson"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Victor J. Hruby | grad student | 2011-2017 | University of Arizona (Chemistry Tree) |
| John M. Streicher | grad student | 2015-2017 | University of Arizona |
| John R. Traynor | post-doc | 2017- |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Olson KM, Devereaux AL, Chatterjee P, et al. (2023) Nitro-benzylideneoxymorphone, a bifunctional mu and delta opioid receptor ligand with high mu opioid receptor efficacy. Frontiers in Pharmacology. 14: 1230053 |
| Olson KM, Hillhouse TM, Burgess GE, et al. (2022) Delta opioid receptor-mediated antidepressant-like effects of diprenorphine in mice. The Journal of Pharmacology and Experimental Therapeutics |
| Disney A, Olson KM, Shafer AM, et al. (2022) Opioid Antagonists from the Orvinol Series as Potential Reversal Agents for Opioid Overdose. Acs Chemical Neuroscience |
| Olson KM, Campbell A, Alt A, et al. (2022) Finding the Perfect Fit: Conformational Biosensors to Determine the Efficacy of GPCR Ligands. Acs Pharmacology & Translational Science. 5: 694-709 |
| Gerak LR, Maguire DR, Cami-Kobeci G, et al. (2022) OREX-1038: a potential new treatment for pain with low abuse liability and limited adverse effects. Behavioural Pharmacology. 33: 377-394 |
| Chan WKB, Olson KM, Wotring JW, et al. (2022) In silico analysis of SARS-CoV-2 proteins as targets for clinically available drugs. Scientific Reports. 12: 5320 |
| Olson KM, Traynor JR, Alt A. (2021) Allosteric Modulator Leads Hiding in Plain Site: Developing Peptide and Peptidomimetics as GPCR Allosteric Modulators. Frontiers in Chemistry. 9: 671483 |
| Keresztes A, Olson K, Nguyen P, et al. (2021) Antagonism of the Mu-Delta Opioid Receptor Heterodimer Enhances Opioid Anti-Nociception by Activating Src and CaMKII Signaling. Pain |
| Hillhouse TM, Olson K, Hallahan JE, et al. (2021) The Journal of Pharmacology and Experimental Therapeutics |
| Olson KM, Hillhouse TE, Sears BF, et al. (2020) Buprenorphine Analogs to Treat Relapse The Faseb Journal. 34: 1-1 |